Complex therapy of external genital endometriosis with immunomodylators

In: Reproductive Endocrinology · 2012 · vol. 0(8) , pp. 6 · doi:10.18370/2309-4117.2012.8.6-9 · W1483435587
article OA: diamond CC0 ⤵ 1 in-corpus citation
AI-generated summary by gemini-2.5-flash-lite, 2026-07-29

Combined hormone therapy with the immunomodulator Immunomax reduced TNF-α, IL-6, and IL-8 levels and prevented endometriosis recurrence by normalizing immunograms.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

In the study of cytokine production in patients with endometriosis after 1 month the cytokine production levels did not change significantly. The level of TNF-α and IL-6 in these patients after combined treatment (hormone therapy) decreased by 21% and IL-8 to 3 times. There was not recurrence of the disease after using immunomodulators in the comparison groups. The use of natural low molecular weight immunomodulator Immunomax in the treatment of endometriosis normalized indicators of immunograms. Combined therapy with the use of immunomodulators improved prognosis and prevent endometriosis recurrence.
Full text 3,524 characters · extracted from oa-doi-fallback · click to expand
Complex therapy of external genital endometriosis with immunomodylators DOI: https://doi.org/10.18370/2309-4117.2012.8.6-9Keywords: endometrіosis, adenomіosis, іmomodulator therapy, cytokіnes, toumor necrosis factorAbstract In the study of cytokine production in patients with endometriosis after 1 month the cytokine production levels did not change significantly. The level of TNF-α and IL-6 in these patients after combined treatment (hormone therapy) decreased by 21% and IL-8 to 3 times. There was not recurrence of the disease after using immunomodulators in the comparison groups. The use of natural low molecular weight immunomodulator Immunomax in the treatment of endometriosis normalized indicators of immunograms. Combined therapy with the use of immunomodulators improved prognosis and prevent endometriosis recurrence. References - Баскаков В.П. Эндометриоидная болезнь / В.П. Баскаков, Ю.В. Цвелев, Е.В. Кира. – СПб., 2002. – 452 с. - Євдокимова В.В. Імунологічне дослідження крові пацієнток, хворих на ендометріоз. Сучасні принципи лікування генітального ендометріозу імуномодуляторами / В.В. Євдокимова // Практична медицина. – 2011. – Вип. 4. – Т. XVII. – С. 67-78. - Евдокимова В.В. Современные принципы лечения наружного генитального эндометриоза и восстановление фертильности. Показатели иммунологического состояния и цитокинового профиля крови / В.В. Евдокимова // Вісник морської медицини. – 2012. – № 2 (56). – С. 60-66. - Ищенко А.И. Эндометриоз. Диагностика и лечение. / А.И. Ищенко, Е.А. Кудрина. – М.: ГЭОТАР-МЕД, 2002. – 115 с. - Крамарева Н.Л. Значение компонентов иммунной системы и генетических факторов в патогенезе и терапии наружного генитального эндометриоза. Автореферат дисс. на соиск. уч. ст. канд. мед. наук. – СПб, 2002. – 24 с. - Линде В.А. Иммунологические аспекты эндометриозов (обзор литературы) / В.А. Линде, Н.А. Татарова, О.И. Гришанина // Проблемы репродукции. – 2008. – № 4. – С. 74-77. - Малашенкова И.К. К вопросу о значении индивидуального подбора иммунокорректоров / И.К. Малашенкова, Н.А. Дидковскип, А.А. Левко // Фарматека. – 2004. –№ 12. – С. 26-33. - Dmowski P.W. Immunology of endometriosis. / P.W. Dmowsli, D.P. Braun // Best Pract Res Clin Obstet Gynaecol. – 2004 – Vol. 18 (2) – P. 245-26. - Guidice L.C., Evers J.L., Healy D.L., WИЛey-Blackwell NY. Endometriosis: Science and Practice / 1 ed. – 2012. – 552 p. - Nothnick W.B. Endometriosis: in search of optimal treatment / W.B. Nothnick // Minerva Ginecol. – 2010. – Vol. 62 (1) – P. 17-31. - Laschke M.W. Anti-angiogenic treatment strategies for the therapy of endometriosis / M.W. Laschke, M.D. Menger // Hum Reprod Update. – 2012. – Vol. 18 (6) – P. 682-702. Downloads Published How to Cite Issue Section License Copyright (c) 2014 В. М. Запорожан, В. В. Евдокимова This work is licensed under a Creative Commons Attribution 4.0 International License. Authors who publish with this journal agree to the following terms: - Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. - Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

Cited by (1)

References (3)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK